Abstract
Abnormal activation of microglia, the resident macrophages in the central nervous system, plays an important role in the pathogenesis of multiple sclerosis (MS). The immune responsive gene 1(IRG1)/itaconate axis is involved in regulating microglia-mediated neuroinflammation. 4-Octyl itaconate (4-OI), a derivative of itaconate, plays a crucial immunomodulatory role in macrophages. This study investigated the effects and mechanisms of action of 4-OI on experimental autoimmune encephalomyelitis (EAE) and inflammatory BV2 microglia. In an EAE mouse model, clinical evaluation was conducted during the disease course. Hematoxylin and eosin staining was performed to assess inflammatory infiltration and Luxol Fast Blue was used to visualize pathological damage. Quantitative real-time polymerase chain reaction, western blotting and immunofluorescence were used to evaluate inflammatory response and microglial function status in EAE mice. BV2 microglia were used to further investigate the effects and mechanisms of action of 4-OI in vitro. 4-OI significantly alleviated the clinical symptoms of EAE, the inflammatory infiltration, and demyelination; reduced the levels of inflammatory factors; and inhibited the classical activation of microglia in the spinal cord. 4-OI successfully suppressed the classical activation of BV2 microglia and decreased the levels of inflammatory factors by activating the Nrf2/HO-1 signaling pathway. Furthermore, 4-OI downregulated IRG1 expression in both EAE mice and inflammatory BV2 microglia. 4-OI attenuates the microglia-mediated neuroinflammation and has promising therapeutic effects in MS.
Similar content being viewed by others
Data Availability
No datasets were generated or analysed during the current study.
References
Ghorbani, Samira, and V Wee Yong. 2021. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis. Brain: A Journal of Neurology 144: 1958–1973. https://doi.org/10.1093/brain/awab059.
Walton, Clare, Rachel King, Lindsay Rechtman, Wendy Kaye, Emmanuelle Leray, Ruth Ann Marrie, Neil Robertson, et al. 2020. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis (Houndmills, Basingstoke, England) 26: 1816–1821. https://doi.org/10.1177/1352458520970841.
Yong, V Wee. 2022. Microglia in multiple sclerosis: Protectors turn destroyers. Neuron 110: 3534–3548. https://doi.org/10.1016/j.neuron.2022.06.023.
Frost, Jeffrey L., and Dorothy P. Schafer. 2016. Microglia: Architects of the Developing Nervous System. Trends in Cell Biology 26: 587–597. https://doi.org/10.1016/j.tcb.2016.02.006.
Sica, Antonio, and Alberto Mantovani. 2012. Macrophage plasticity and polarization: In vivo veritas. The Journal of Clinical Investigation 122: 787–795. https://doi.org/10.1172/JCI59643.
Plastini, Melanie J., Haritha L. Desu, and Roberta Brambilla. 2020. Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis. Frontiers in Cellular Neuroscience 14: 269. https://doi.org/10.3389/fncel.2020.00269.
Peace, Christian G., and Luke Aj O’Neill. 2022. The role of itaconate in host defense and inflammation. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI148548.
Shi, Xuan, Huanping Zhou, Juan Wei, Wei Mo, Quanfu Li, and Xin Lv. 2022. The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases. Redox Biology 58: 102553. https://doi.org/10.1016/j.redox.2022.102553.
Li, Yang, Xing Chen, Hua Zhang, Jie Xiao, Chuanlei Yang, Weiqiang Chen, Zhanjie Wei, Xinzhong Chen, and Jinping Liu. 2020. 4-Octyl Itaconate Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting Oxidative Stress and Inflammation. Drug Design, Development and Therapy 14: 5547–5558. https://doi.org/10.2147/DDDT.S280922.
Li, Ruidong, Wenchang Yang, Yuping Yin, Peng Zhang, Yaxin Wang, and Kaixiong Tao. 2021. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis. Oxidative Medicine and Cellular Longevity 2021: 9932099. https://doi.org/10.1155/2021/9932099.
He, Sunyue, Yuchen Zhao, Guoxing Wang, Qiaofang Ke, Nan Wu, Lusi Lu, Jiahua Wu, et al. 2023. 4-Octyl itaconate attenuates glycemic deterioration by regulating macrophage polarization in mouse models of type 1 diabetes. Molecular Medicine (Cambridge, Mass.) 29: 31. https://doi.org/10.1186/s10020-023-00626-5.
Li, Weizhen, Yangguang Li, Jiaqi Kang, Haiyang Jiang, Wenbin Gong, Lijuan Chen, Wu. Cunxia, et al. 2023. 4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING. Cell Reports 42: 112145. https://doi.org/10.1016/j.celrep.2023.112145.
Wu, Ya.-xian, Ya.-ru Zhang, Feng-juan Jiang, Shuai He, Yan-li Zhang, Dan Chen, Ying Tong, Yun-juan Nie, and Qing-feng Pang. 2023. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition. Inflammation Research 72: 1133–1145. https://doi.org/10.1007/s00011-023-01733-z.
Giralt, Mercedes, Amalia Molinero, and Juan Hidalgo. 2018. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG35–55 in the Mouse. Methods in Molecular Biology (Clifton, N.J.) 1791: 227–232. https://doi.org/10.1007/978-1-4939-7862-5_17.
Henderson, John, Sharadha Dayalan Naidu, Albena T. Dinkova-Kostova, Stefan Przyborski, Richard Stratton, and Steven O′ Reilly. 2021. The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis. Cells. https://doi.org/10.3390/cells10082053.
Wu, Yu-Tong., Xu. Wen-Ting, Li. Zheng, Sheng Wang, Juan Wei, Mei-Yun. Liu, Huan-Ping. Zhou, Quan-Fu. Li, Xuan Shi, and Xin Lv. 2023. 4-octyl itaconate ameliorates alveolar macrophage pyroptosis against ARDS via rescuing mitochondrial dysfunction and suppressing the cGAS/STING pathway. International Immunopharmacology 118: 110104. https://doi.org/10.1016/j.intimp.2023.110104.
Kuo, Ping-Chang., Wen-Tsan. Weng, Barbara A. Scofield, Hallel C. Paraiso, Dennis A. Brown, Pei-Yu. Wang, and I-Chen Yu, and Jui-Hung Yen. 2020. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation 17: 138. https://doi.org/10.1186/s12974-020-01768-7.
Aso, Kuniyuki, Michihito Kono, Masatoshi Kanda, Yuki Kudo, Kodai Sakiyama, Ryo Hisada, Kohei Karino, et al. 2023. Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming. Nature Communications 14: 984. https://doi.org/10.1038/s41467-023-36594-x.
Seim, Gretchen L., Emily C. Britt, Steven V. John, Franklin J. Yeo, Aaron R. Johnson, Richard S. Eisenstein, David J. Pagliarini, and Jing Fan. 2019. Two-stage metabolic remodelling in macrophages in response to lipopolysaccharide and interferon-γ stimulation. Nature Metabolism 1: 731–742. https://doi.org/10.1038/s42255-019-0083-2.
McGettrick, Anne F., and Luke Aj O’Neill. 2023. Two for the price of one: Itaconate and its derivatives as an anti-infective and anti-inflammatory immunometabolite. Current Opinion in Immunology 80: 102268. https://doi.org/10.1016/j.coi.2022.102268.
Lampropoulou, Vicky, Alexey Sergushichev, Monika Bambouskova, Sharmila Nair, Emma E. Vincent, Ekaterina Loginicheva, Luisa Cervantes-Barragan, et al. 2016. Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. Cell Metabolism 24: 158–166. https://doi.org/10.1016/j.cmet.2016.06.004.
Domínguez-Andrés, Jorge, Boris Novakovic, Yang Li, Brendon P. Scicluna, Mark S. Gresnigt, Rob J W. Arts, Marije Oosting, et al. 2019. The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity. Cell Metabolism 29: 211-220.e5. https://doi.org/10.1016/j.cmet.2018.09.003.
Mills, Evanna L., Dylan G. Ryan, Hiran A. Prag, Dina Dikovskaya, Deepthi Menon, Zbigniew Zaslona, Mark P. Jedrychowski, et al. 2018. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556: 113–117. https://doi.org/10.1038/nature25986.
Absinta, Martina, Dragan Maric, Marjan Gharagozloo, Thomas Garton, Matthew D. Smith, Jing Jin, Kathryn C. Fitzgerald, et al. 2021. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis. Nature 597: 709–714. https://doi.org/10.1038/s41586-021-03892-7.
Schetters, Sjoerd T T., Diego Gomez-Nicola, Juan J. Garcia-Vallejo, and Yvette Van Kooyk. 2017. Neuroinflammation: Microglia and T Cells Get Ready to Tango. Frontiers in Immunology 8: 1905. https://doi.org/10.3389/fimmu.2017.01905.
Ferguson, B., M. K. Matyszak, M. M. Esiri, and V. H. Perry. 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120: 393–9. https://doi.org/10.1093/brain/120.3.393.
van Horssen, Jack, Shailender Singh, Susanne van der Pol, Markus Kipp, Jamie L. Lim, Laura Peferoen, Wouter Gerritsen, et al. 2012. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. Journal of Neuroinflammation 9: 156. https://doi.org/10.1186/1742-2094-9-156.
Leitner, Dominique F., Bozho Todorich, Xuesheng Zhang, and James R. Connor. 2015. Semaphorin4A Is Cytotoxic to Oligodendrocytes and Is Elevated in Microglia and Multiple Sclerosis. ASN Neuro. https://doi.org/10.1177/1759091415587502.
Suzumura, Akio. 2009. Neurotoxicity by microglia: the mechanisms and potential therapeutic strategy. Fukuoka Igaku Zasshi = Hukuoka Acta Medica 100: 243–7.
Magliozzi, Roberta, Owain William Howell, Pascal Durrenberger, Eleonora Aricò, Rachel James, Carolina Cruciani, Cheryl Reeves, Federico Roncaroli, Richard Nicholas, and Richard Reynolds. 2019. Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis. Journal of Neuroinflammation 16: 259. https://doi.org/10.1186/s12974-019-1650-x.
Giles, David A., Jesse M. Washnock-Schmid, Patrick C. Duncker, Somiah Dahlawi, Gerald Ponath, David Pitt, and Benjamin M. Segal. 2018. Myeloid cell plasticity in the evolution of central nervous system autoimmunity. Annals of Neurology 83: 131–141. https://doi.org/10.1002/ana.25128.
Dong, Yifei, Charlotte D’Mello, William Pinsky, Brian M. Lozinski, Deepak K. Kaushik, Samira Ghorbani, Dorsa Moezzi, et al. 2021. Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nature Neuroscience 24: 489–503. https://doi.org/10.1038/s41593-021-00801-z.
Liu, Ruisi, Yueling Gong, Chenyi Xia, Yemin Cao, Cheng Zhao, and MMingmei Zhou. 2023. Itaconate: A promising precursor for treatment of neuroinflammation associated depression. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 167: 115521. https://doi.org/10.1016/j.biopha.2023.115521.
Choi, Jong Hee, Oh. Jinhee, Min Jung Lee, Seong-Gyu. Ko, Seung-Yeol. Nah, and Ik-Hyun. Cho. 2021. Gintonin mitigates experimental autoimmune encephalomyelitis by stabilization of Nrf2 signaling via stimulation of lysophosphatidic acid receptors. Brain, behavior, and Immunity 93: 384–398. https://doi.org/10.1016/j.bbi.2020.12.004.
Liao, Shan-Ting., Chao Han, Xu. Ding-Qiao, Fu. Xiao-Wei, Jun-Song. Wang, and Ling-Yi. Kong. 2019. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nature Communications 10: 5091. https://doi.org/10.1038/s41467-019-13078-5.
Tang, Chun, Xiaohua Wang, Yingying Xie, Xiaoyan Cai, Yu. Na, Hu. Yudan, and Zhihua Zheng. 2018. 4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 51: 979–990. https://doi.org/10.1159/000495400.
Eom, Taekil, In-Hye. Kim, Hyung-Joo. Kim, YounHee Choi, and Taek-Jeong. Nam. 2021. Calystegia soldanella Extract Exerts Anti-Oxidative and Anti-Inflammatory Effects via the Regulation of the NF-κB/Nrf-2 Pathways in Mouse Macrophages. Antioxidants (Basel, Switzerland). https://doi.org/10.3390/antiox10101639.
Rojo, Ana I., Nadia G. Innamorato, Ana M. Martín-Moreno, María L. De Ceballos, Masayuki Yamamoto, and Antonio Cuadrado. 2010. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson’s disease. Glia 58: 588–598. https://doi.org/10.1002/glia.20947.
Kim, Byung-Chul., Woo-Kwang. Jeon, Hye-Young. Hong, Kyung-Bum. Jeon, Jang-Hee. Hahn, Young-Myeong. Kim, Satoshi Numazawa, Takemi Yosida, Eun-Hee. Park, and Chang-Jin. Lim. 2007. The anti-inflammatory activity of Phellinus linteus (Berk. & M.A. Curt.) is mediated through the PKCdelta/Nrf2/ARE signaling to up-regulation of heme oxygenase-1. Journal of Ethnopharmacology 113: 240–247. https://doi.org/10.1016/j.jep.2007.05.032.
Cai, Dawei, Shasha Yin, Jun Yang, Qing Jiang, and Wangsen Cao. 2015. Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. Arthritis Research & Therapy 17: 269. https://doi.org/10.1186/s13075-015-0774-3.
Jin, Wei, Handong Wang, Wei Yan, Xu. Lizhi, Xiaoliang Wang, Xiaoning Zhao, Xiaohe Yang, Gang Chen, and Yan Ji. 2008. Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators of Inflammation 2008: 725174. https://doi.org/10.1155/2008/725174.
Chi, Xinjin, Weifeng Yao, Hua Xia, Yi. Jin, Xi. Li, Jun Cai, and Ziqing Hei. 2015. Elevation of HO-1 Expression Mitigates Intestinal Ischemia-Reperfusion Injury and Restores Tight Junction Function in a Rat Liver Transplantation Model. Oxidative Medicine and Cellular Longevity 2015: 986075. https://doi.org/10.1155/2015/986075.
Saha, Sarmistha, Brigitta Buttari, Emiliano Panieri, Elisabetta Profumo, and Luciano Saso. 2020. An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules25225474.
Michelucci, Alessandro, Thekla Cordes, Jenny Ghelfi, Arnaud Pailot, Norbert Reiling, Oliver Goldmann, Tina Binz, et al. 2013. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proceedings of the National Academy of Sciences of the United States of America 110: 7820–7825. https://doi.org/10.1073/pnas.1218599110.
Li, Yangguang, Wenbin Gong, Weizhen Li, Peizhao Liu, Juanhan Liu, Haiyang Jiang, Tao Zheng, et al. 2023. The IRG1-Itaconate axis: A regulatory hub for immunity and metabolism in macrophages. International Reviews of Immunology 42: 364–378. https://doi.org/10.1080/08830185.2022.2067153.
Yi, Zhongjie, Meihong Deng, Melanie J. Scott, Guang Fu, Patricia A. Loughran, Zhao Lei, Shilai Li, et al. 2020. Immune-Responsive Gene 1/Itaconate Activates Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocytes to Protect Against Liver Ischemia-Reperfusion Injury. Hepatology (Baltimore, Md.) 72: 1394–1411. https://doi.org/10.1002/hep.31147.
Zhu, Dongdong, Yuanyu Zhao, Yi. Luo, Xiaoqian Qian, Zhen Zhang, Gengru Jiang, and Fengfu Guo. 2021. Irg1-itaconate axis protects against acute kidney injury via activation of Nrf2. American Journal of Translational Research 13: 1155–1169.
Yang, Wenchang, Yaxin Wang, Yongzhou Huang, Tao Wang, Chengguo Li, Peng Zhang, Weizhen Liu, Yuping Yin, Ruidong Li, and Kaixiong Tao. 2024. Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory response. Inflammopharmacology 32: 419–432. https://doi.org/10.1007/s10787-023-01278-x.
Funding
This work was supported by the National Natural Science Foundation of China (grant numbers: 81771363); Tianjin Key Medical Discipline (Specialty) Construction Project (grant numbers: TJYXZDXK-004A); Scientific Research Program of Tianjin Municipal Education Commission (grant numbers: 2022KJ244).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, experimental operation and data analysis were performed by Ning Zhao, Ming Yi, Lin-Jie Zhang. The first draft of the manuscript was written by Ning Zhao and Ming Yi, and all authors commented on previous versions of the manuscript. All authors reviewed and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
All animal experiments were approved by the Ethics Committee of Tianjin Medical University General Hospital (IRB2024-DW-04) and conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhao, N., Yi, M., Zhang, LJ. et al. 4-Octyl Itaconate Attenuates Neuroinflammation in Experimental Autoimmune Encephalomyelitis Via Regulating Microglia. Inflammation (2024). https://doi.org/10.1007/s10753-024-02050-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10753-024-02050-1